Trial Profile
Maternal Buprenorphine-naloxone Treatment During the Perinatal Period: Fetal and Infant Effects
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Feb 2024
Price :
$35
*
At a glance
- Drugs Buprenorphine/naloxone (Primary) ; Methadone
- Indications Opioid-related disorders
- Focus Therapeutic Use
- 20 Feb 2024 Status changed from active, no longer recruiting to completed.
- 17 Aug 2023 Status changed from recruiting to active, no longer recruiting.
- 30 Dec 2022 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.